Finanzwire Finanzwire
Basculer en Français
10047 Companies
204808 Keywords
135057 Articles
108583 Press releases
Headlines Articles Press releases MEDINCELL Remove
  1. Home
  2. Companies
  3. MEDINCELL
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/10/2024 at 18:05, 1 year 10 months ago

    Medincell announces details on capital and voting rights in accordance with regulations

    Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
  • BRIEF

    published on 05/08/2024 at 12:35, 1 year 10 months ago

    Positive Results for the SOLARIS Phase 3 Trial of Olanzapine

    Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
  • PRESS RELEASE

    published on 05/08/2024 at 12:30, 1 year 10 months ago

    Inside Information / Other news releases

    Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia
    Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
    Logo of MEDINCELL
  • BRIEF

    published on 05/08/2024 at 09:05, 1 year 10 months ago

    Medincell Temporarily Suspends its Euronext Paris Listing

    Euronext Paris Press Release Financial Markets Medincell Share Suspension
  • PRESS RELEASE

    published on 05/08/2024 at 09:00, 1 year 10 months ago

    Inside Information / Other news releases

    Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs
    Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
    Logo of MEDINCELL
Previous page
1 ... 6 7
Accesswire
  • Published on 03/17/2026 at 13:30, 6 hours 40 minutes ago

    Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026

  • Published on 03/17/2026 at 13:30, 6 hours 40 minutes ago

    Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project

  • Published on 03/17/2026 at 13:00, 7 hours 10 minutes ago

    Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland

  • Published on 03/17/2026 at 13:00, 7 hours 10 minutes ago

    High-Resolution Airborne Survey Completed at Music Valley HREE Project

  • Published on 03/17/2026 at 12:30, 7 hours 40 minutes ago

    Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho

View all ACCESSWIRE
EQS Group
  • Published on 03/17/2026 at 18:07, 2 hours 3 minutes ago

    POS-Transaction in Own Shares

  • Published on 03/17/2026 at 17:58, 2 hours 12 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 03/17/2026 at 17:45, 2 hours 25 minutes ago

    FIGEAC AÉRO: THREE NEW WINS IN MEXICO

  • Published on 03/17/2026 at 15:30, 4 hours 40 minutes ago

    Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy

  • Published on 03/17/2026 at 15:19, 4 hours 51 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC

View all EQS
Les Echos
  • Published on 03/17/2026 at 07:00, 13 hours 10 minutes ago

    Invitation to the Extraordinary General Meeting of shareholders

  • Published on 03/16/2026 at 18:00, 1 day 2 hours ago

    Disclosure of trading in own shares from 09/03/2026 to 13/03/2026

  • Published on 03/16/2026 at 17:58, 1 day 2 hours ago

    Aéroports de Paris S.A - February 2026 traffic figures

  • Published on 03/16/2026 at 17:56, 1 day 2 hours ago

    Reporting on share buyback transactions carried out between March 9 and March 13, 2026

  • Published on 03/16/2026 at 17:45, 1 day 2 hours ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy